Other headlines:Barco lands contract with Italian mammography firmAmerinet expands Fujifilm offerings
Siemens Healthcare will launch tomorrow at the SNM meeting in Toronto newly enhanced software for viewing data acquired on its Inveon preclinical PET scanner. The upgraded Inveon Research Workplace (IRW) offers an expanded tool set for image visualization and data analysis, as well as new tools for cardiac PET applications. IRW version 3.0 enables visualization and analysis of dual-gated dynamic PET data free from cardiac and respiratory motion artifacts, according to the company. The new software also allows for quick and accurate high-resolution image data export, representation, and interpretation, while delivering such features as arbitrary image reorientation and image filtering.
Medical imaging specialist Barco will integrate newly available 20-inch LCD panels into mammography workstations under a supply contract signed with Bologna, Italy-based IMS (Internazionale Medico Scientifica). The MDRC-2120 panels, featuring a resolution of 1600 x 1200 pixels, will be part of IMS's Raffaello image acquisition workstations. MDRC-2120 shows digitally acquired images with better contrast and higher brightness, thanks to the high-quality LCD panel and preset DICOM lookup table, according to Barco.
Group purchasing organization Amerinet has added Synapse cardiovascular and Synapse RIS to its existing Fujifilm contracts. With this addition, Amerinet members have access to the complete Fujifilm product portfolio, including PACS, digital x-ray, digital mammography, and film.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.